Mississauga, ON -- (SBWire) -- 07/10/2013 --AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “InVivo Therapeutics and New York Mets Host Team for First Ever MLB Spinal Cord Injury Awareness Day.”
Companies mentioned in this article include Geron (Nasdaq:GERN), BioTime, Inc. (AMEX:BTX) and InVivo Therapeutics (OTCBB:NVIV).
Article Excerpt:
It’s been four and one-half years now since the U.S. Food and Drug Administration approved the request from Geron Corporation to test embryonic stem cells on a handful of patients with severe spinal cord injuries. The stem cells business has grown leaps and bounds in a relatively short period of time since that historic moment. In addition to a host of clinical trials moving far beyond early stages, the controversy over embryonic stem cells has cooled with a budding library of research demonstrating the potency and therapeutic benefit of adult stem cells.
On that point, in May, scientists for the first time were able to make an embryonic stem cell line from human skin cells by reprogramming the cells back to their embryonic state.
Ultimately, Geron (Nasdaq:GERN) hit some roadblocks in the research and shuttered its stem cell business, eventually striking a deal to sell the assets to BioTime, Inc. (AMEX:BTX) earlier this year.
Although advancements have certainly been made, spinal cord injuries, or SCI, have remained stubbornly resistant to therapies with current standards of care primarily focused on symptoms, rather than the underlying pathology. As noted in a press release on Wednesday by InVivo Therapeutics (OTCBB:NVIV), the average lifetime cost of care for quadriplegic patients can exceed $6.2 million.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/370/invivo-therapeutics-and-new-york-mets-host-team-for-first-ever-mlb-spinal-cord-injury-awareness-day.htm
About AllPennyStocks.com:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.
All Penny Stocks.com News: InVivo Therapeutics and New York Mets Host Team for First Ever MLB Spinal Cord Injury Awareness Day